MEAT-TECH 3D LTD - ADR (MITC) Stock Fundamental Analysis

NASDAQ:MITC • US5834351026

3.34 USD
+0.03 (+0.91%)
Last: Aug 2, 2022, 08:21 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, MITC scores 1 out of 10 in our fundamental rating. MITC was compared to 87 industry peers in the Food Products industry. While MITC seems to be doing ok healthwise, there are quite some concerns on its profitability. MITC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MITC had negative earnings in the past year.
MITC Yearly Net Income VS EBIT VS OCF VS FCFMITC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -44.33%
ROE N/A
ROIC -35.95%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MITC Yearly ROA, ROE, ROICMITC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 -50 -100 -150

1.3 Margins

  • MITC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MITC Yearly Profit, Operating, Gross MarginsMITC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MITC is destroying value.
  • MITC has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MITC has been reduced compared to a year ago.
MITC Yearly Shares OutstandingMITC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 20M 40M 60M 80M 100M
MITC Yearly Total Debt VS Total AssetsMITC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

  • MITC has an Altman-Z score of 81.15. This indicates that MITC is financially healthy and has little risk of bankruptcy at the moment.
  • MITC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 81.15
ROIC/WACC-4.76
WACC7.55%
MITC Yearly LT Debt VS Equity VS FCFMITC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 7.94 indicates that MITC has no problem at all paying its short term obligations.
  • MITC has a Quick Ratio of 7.94. This indicates that MITC is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 7.94
Quick Ratio 7.94
MITC Yearly Current Assets VS Current LiabilitesMITC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.61% over the past year.
EPS 1Y (TTM)54.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MITC Yearly Revenue VS EstimatesMITC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 10K 20K 30K 40K 50K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • MITC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MITC Price Earnings VS Forward Price EarningsMITC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -24.24
MITC Per share dataMITC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MITC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MEAT-TECH 3D LTD - ADR

NASDAQ:MITC (8/2/2022, 8:21:07 PM)

3.34

+0.03 (+0.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-31
Earnings (Next)08-19
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap420.07M
Revenue(TTM)N/A
Net Income(TTM)-18.02M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.17
P/tB N/A
EV/EBITDA -24.24
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.3
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -44.33%
ROE N/A
ROCE N/A
ROIC -35.95%
ROICexc N/A
ROICexgc -55.76%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.94
Quick Ratio 7.94
Altman-Z 81.15
F-Score4
WACC7.55%
ROIC/WACC-4.76
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MEAT-TECH 3D LTD - ADR / MITC FAQ

What is the ChartMill fundamental rating of MEAT-TECH 3D LTD - ADR (MITC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MITC.


What is the valuation status of MEAT-TECH 3D LTD - ADR (MITC) stock?

ChartMill assigns a valuation rating of 1 / 10 to MEAT-TECH 3D LTD - ADR (MITC). This can be considered as Overvalued.


How profitable is MEAT-TECH 3D LTD - ADR (MITC) stock?

MEAT-TECH 3D LTD - ADR (MITC) has a profitability rating of 1 / 10.


Can you provide the financial health for MITC stock?

The financial health rating of MEAT-TECH 3D LTD - ADR (MITC) is 9 / 10.